Assembly Biosciences (ASMB) analyst forecast and price target
Analyst forecast
Consensus of 5 analyst ratings
Based on 3 analyst targets
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| Mizuho | Maintained | Outperform | $45.00 from $53.00 | Sep 1, 2026 |
| UBS | Initiated Coverage | Buy | $52.00 | Sep 1, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $50.00 | Aug 18, 2026 |
| Mizuho | Maintained | Outperform | $45.00 from $40.00 | Jun 15, 2026 |
| Guggenheim | Maintained | Buy | $43.00 | May 28, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $50.00 | May 4, 2026 |
| Guggenheim | Maintained | Buy | $43.00 from $39.00 | Apr 6, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $50.00 | Mar 26, 2026 |
| HC Wainwright & Co. | Maintained | Buy | $50.00 | Dec 22, 2025 |
| Mizuho | Maintained | Outperform | $40.00 from $29.00 | Nov 20, 2025 |
| HC Wainwright & Co. | Maintained | Buy | $50.00 | Oct 14, 2025 |
| JMP Securities | Initiated Coverage | Market Outperform | $38.00 | Sep 24, 2025 |
| Guggenheim | Maintained | Buy | $39.00 from $31.00 | Sep 8, 2025 |
| HC Wainwright & Co. | Initiated Coverage | Buy | $50.00 | Aug 18, 2025 |
| Guggenheim | Initiated Coverage | Buy | $31.00 | Mar 25, 2025 |
| HC Wainwright & Co. | Maintained | Neutral | — | Mar 24, 2025 |
| HC Wainwright & Co. | Maintained | Neutral | — | Dec 27, 2024 |
| HC Wainwright & Co. | Maintained | Neutral | — | Sep 24, 2024 |
| Jefferies | Upgraded | Hold → Buy | $35.00 from $2.00 | Sep 20, 2024 |
| HC Wainwright & Co. | Maintained | Neutral | — | Jun 20, 2024 |
Frequently asked questions
What is the price target for ASMB stock?
The average 12-month analyst price target for Assembly Biosciences (ASMB) is $49.00, with a high estimate of $52.00 and a low of $45.00, across 3 analysts.
Is ASMB a buy, sell, or hold?
Analysts covering Assembly Biosciences currently average a Buy rating: 5 buy, 0 hold and 0 sell, from 5 analysts. Ratings reflect analyst opinion, not investment advice.
What upside do analysts see for ASMB?
The average price target of $49.00 implies 140.90% upside from the last price of $20.34.
What is the latest analyst rating on ASMB?
On Sep 1, 2026, Mizuho maintained Assembly Biosciences at Outperform with a price target of $45.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.